首页> 外文会议>Annual International Conference of the IEEE Engineering in Medicine and Biology Society >On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics
【24h】

On a Novel, Simplified Model Framework Describing Ascorbic Acid Concentration Dynamics

机译:关于描述抗坏血酸浓度动态的新型,简化的模型框架

获取原文

摘要

Ascorbic acid is an essential aminoacid which interacts in several parts of the human body metabolism. The ascorbic acid concentration is controlled by homeostasis, a biological, autonomous control function in the body. Humans are not able to produce ascorbic acid, and the ascorbic acid concentration is maintained by daily oral digestion. Ascorbic acid is buffered in various tissues, such as the adrenal glands, brain, muscles, and other. Excessive ascorbic acid is extracted from the body through urine and intestines. Measuring ascorbic acid concentration in the body is challenging, and special procedures must be followed when extracting a blood sample and performing a concentration analysis. This paper presents a novel, simplified model framework of the ascorbic acid homeostasis in the human body plasma and tissues, including tissues such as adrenal glands, brain, liver, muscles and bone marrow. These tissues also act as ascorbic acid concentration buffers, in case of low oral supply. The dynamic model framework is based on mass balances of ascorbate acid in various tissues, including tissue buffer terms involving the intestine, kidney, adrenal glands, and other critical and noncritical tissues. The interaction between buffer tissues and fluids is maintained by the body homeostasis using chemical transport protein molecules. Additional usage terms describing energy metabolism, body growth, and immune system response are also included. This dynamic model framework, including the ascorbic acid concentration control system, is simulated with assumed parameters based on available literature. The results indicates that further investigations using experiments, in addition to adaptive model parameter estimation schemes and additional model verification tests are needed in order to identify the various model framework parameters to fit the human body ascorbic acid homeostasis and pharmacokinetics.
机译:抗坏血酸是一种必需的氨基酸,其在人体代谢的几个部分中相互作用。抗坏血酸浓度由稳态,生物,自主控制功能控制在体内。人类无法生产抗坏血酸,并且通过每日口服消化维持抗坏血酸浓度。在各种组织中缓冲抗坏血酸,例如肾上腺,脑,肌肉等。通过尿液和肠道从体内提取过量的抗坏血酸。测量体内的抗坏血酸浓度是具有挑战性的,并且当提取血液样品并进行浓度分析时,必须遵循特殊程序。本文呈现了人体血浆和组织中抗坏血酸稳态的新型简化模型框架,包括肾上腺,脑,肝,肌肉和骨髓如组织。这些组织还充当抗坏血酸浓度缓冲剂,在口服低口服。动态模型框架基于各种组织中的抗坏血酸酸的质量平衡,包括涉及肠,肾,肾上腺和其他关键和非临界组织的组织缓冲术语。缓冲组织和流体之间的相互作用由身体稳态使用化学传输蛋白质分子维持。还包括额外的使用术语,描述能量代谢,身体生长和免疫系统反应。这种动态模型框架(包括抗坏血酸浓度控制系统)用基于可用文献的假设参数模拟。结果表明,除了适应性模型参数估计方案和其他模型验证测试之外,还需要使用实验进一步调查,以便识别适合人体抗坏血酸稳态和药代动力学的各种模型框架参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号